Hints and tips:
Related Special Reports
...Pharma groups are optimistic about the potential for new weight loss and diabetes drugs known as GLP-1s to treat liver diseases....
...Crab, which causes life-threatening illnesses in hospital patients, is classed as a priority concern by the WHO and an urgent threat by the US Centers for Disease Control and Prevention....
...Scientists have developed a simple and affordable blood test to help spot cancer cases in low- and middle-income countries, marking the latest move to boost disease prevention among ageing populations....
...the first pharmaceutical treatment for the underlying disease,” said Emmick....
...’s UCSF Memory and Aging Center, which played a role in the Leqembi trial....
...In newborns, “congenital” syphilis — which can cause miscarriages, stillbirths, or life-long medical problems — was up more than tenfold between 2012 and 2022, according to the US Centres for Disease Control...
...This reflects both late diagnosis and the higher risk that Black men appear to have of developing the disease, for reasons that are still not well understood....
...The EU has approved a new antibiotic for serious illnesses such as pneumonia and urinary tract infections, marking a step forward in the drive to combat the growing resistance of “superbugs” to existing...
...“We are now training in a much more open-ended way and we are discovering almost abilities in these models that they weren’t explicitly trained for,” said Thirunavukarasu, who carried out the research while...
...The research charity noted there had been improvements in diagnosing and treating the disease in the years since the latest trial, conducted by the universities of Bristol, Oxford and Cambridge, began....
...Initially, the 42-year-old’s condition was believed to be non-malignant, but post-operative tests found she had the disease. She did not reveal the form of the cancer, or its stage....
...A person in Texas has contracted the second known human case of H5N1 bird flu in the US, the Centers for Disease Control and Prevention said....
...“MLD places an enormous emotional and economic burden on families and caregivers — who face substantial wage loss and added expenses each year as the disease progresses — all while dealing with the unquantifiable...
...Still, the nature of the procedures limits the audience for BCIs. Patients with degenerative diseases or paralysis have far more to gain than the average consumer....
...Clarifying which companies are responsible for innovations will be “even more important” as pharma companies explore uses for mRNA in cancer, autoimmune diseases and other viruses, said Anna Wolters-Höhne...
...Belkaid is a specialist in the relationship between microbes and the immune system. She was previously director of the US National Institutes of Health Center for Human Immunology....
...This is a potential problem, for those adults themselves and for their relatives or carers. And it is just one of many pandemic hangovers that deserve attention....
...The figures for January and February included 52 confirmed cases among babies aged under three months who are most at risk of dying from the disease....
...Its best-selling Tagrisso drug showed a “statistically significant and highly clinically meaningful” improvement in preventing the progression of a version of the most common form of the disease, the company...
...German pharma group Boehringer Ingelheim is commercialising a Zealand treatment for both obesity and liver disease that is set to launch by 2028....
...A decision not to administer treatment or to end treatment for a disease is lawful in the UK. But to help someone die is not, and carries a maximum prison sentence of 14 years....
...This is creating an “urgent need” for policies to promote prevention, encourage weight loss and cut disease risks, says the paper published on Thursday in The Lancet....
...In October, pharmaceuticals companies Eisai and Eli Lilly unveiled research showing the benefits of using new Alzheimer’s drugs very early in the development of the disease....
...Shockwave has the market-leading treatment for patients with calcified arterial lesions, which is a major contributor to the risk of heart disease or a heart attack....
International Edition